Global Alzheimer's Disease Therapeutics and Diagnostics Market Insights and Forecast to 2031

Report ID: 1197214 | Published Date: Jan 2025 | No. of Page: 107 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Biomarkers
        1.2.3 Cholinesterase inhibitors
        1.2.4 NMDA receptor antagonists
        1.2.5 Brain imaging
        1.2.6 Blood tests
    1.3 Market by Application
        1.3.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Drugs Market
        1.3.3 Diagnostics Market
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Perspective (2017-2028)
    2.2 Alzheimer's Disease Therapeutics and Diagnostics Growth Trends by Region
        2.2.1 Alzheimer's Disease Therapeutics and Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Alzheimer's Disease Therapeutics and Diagnostics Historic Market Size by Region (2017-2022)
        2.2.3 Alzheimer's Disease Therapeutics and Diagnostics Forecasted Market Size by Region (2023-2028)
    2.3 Alzheimer's Disease Therapeutics and Diagnostics Market Dynamics
        2.3.1 Alzheimer's Disease Therapeutics and Diagnostics Industry Trends
        2.3.2 Alzheimer's Disease Therapeutics and Diagnostics Market Drivers
        2.3.3 Alzheimer's Disease Therapeutics and Diagnostics Market Challenges
        2.3.4 Alzheimer's Disease Therapeutics and Diagnostics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Alzheimer's Disease Therapeutics and Diagnostics Players by Revenue
        3.1.1 Global Top Alzheimer's Disease Therapeutics and Diagnostics Players by Revenue (2017-2022)
        3.1.2 Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share by Players (2017-2022)
    3.2 Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Alzheimer's Disease Therapeutics and Diagnostics Revenue
    3.4 Global Alzheimer's Disease Therapeutics and Diagnostics Market Concentration Ratio
        3.4.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Alzheimer's Disease Therapeutics and Diagnostics Revenue in 2021
    3.5 Alzheimer's Disease Therapeutics and Diagnostics Key Players Head office and Area Served
    3.6 Key Players Alzheimer's Disease Therapeutics and Diagnostics Product Solution and Service
    3.7 Date of Enter into Alzheimer's Disease Therapeutics and Diagnostics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Alzheimer's Disease Therapeutics and Diagnostics Breakdown Data by Type
    4.1 Global Alzheimer's Disease Therapeutics and Diagnostics Historic Market Size by Type (2017-2022)
    4.2 Global Alzheimer's Disease Therapeutics and Diagnostics Forecasted Market Size by Type (2023-2028)
5 Alzheimer's Disease Therapeutics and Diagnostics Breakdown Data by Application
    5.1 Global Alzheimer's Disease Therapeutics and Diagnostics Historic Market Size by Application (2017-2022)
    5.2 Global Alzheimer's Disease Therapeutics and Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size (2017-2028)
    6.2 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type
        6.2.1 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2017-2022)
        6.2.2 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2023-2028)
        6.2.3 North America Alzheimer's Disease Therapeutics and Diagnostics Market Share by Type (2017-2028)
    6.3 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application
        6.3.1 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2017-2022)
        6.3.2 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2023-2028)
        6.3.3 North America Alzheimer's Disease Therapeutics and Diagnostics Market Share by Application (2017-2028)
    6.4 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country
        6.4.1 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2017-2022)
        6.4.2 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size (2017-2028)
    7.2 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type
        7.2.1 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2017-2022)
        7.2.2 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2023-2028)
        7.2.3 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Share by Type (2017-2028)
    7.3 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application
        7.3.1 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2017-2022)
        7.3.2 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2023-2028)
        7.3.3 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Share by Application (2017-2028)
    7.4 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country
        7.4.1 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2017-2022)
        7.4.2 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Size (2017-2028)
    8.2 Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type
        8.2.1 Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Share by Type (2017-2028)
    8.3 Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application
        8.3.1 Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Share by Application (2017-2028)
    8.4 Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Size by Region
        8.4.1 Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size (2017-2028)
    9.2 Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type
        9.2.1 Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2017-2022)
        9.2.2 Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2023-2028)
        9.2.3 Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Share by Type (2017-2028)
    9.3 Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application
        9.3.1 Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2017-2022)
        9.3.2 Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2023-2028)
        9.3.3 Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Share by Application (2017-2028)
    9.4 Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country
        9.4.1 Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2017-2022)
        9.4.2 Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Market Size (2017-2028)
    10.2 Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type
        10.2.1 Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Market Share by Type (2017-2028)
    10.3 Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application
        10.3.1 Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Market Share by Application (2017-2028)
    10.4 Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country
        10.4.1 Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Namenda
        11.1.1 Namenda Company Details
        11.1.2 Namenda Business Overview
        11.1.3 Namenda Alzheimer's Disease Therapeutics and Diagnostics Introduction
        11.1.4 Namenda Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022)
        11.1.5 Namenda Recent Developments
    11.2 Aricept
        11.2.1 Aricept Company Details
        11.2.2 Aricept Business Overview
        11.2.3 Aricept Alzheimer's Disease Therapeutics and Diagnostics Introduction
        11.2.4 Aricept Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022)
        11.2.5 Aricept Recent Developments
    11.3 Exelon
        11.3.1 Exelon Company Details
        11.3.2 Exelon Business Overview
        11.3.3 Exelon Alzheimer's Disease Therapeutics and Diagnostics Introduction
        11.3.4 Exelon Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022)
        11.3.5 Exelon Recent Developments
    11.4 Solanezumab
        11.4.1 Solanezumab Company Details
        11.4.2 Solanezumab Business Overview
        11.4.3 Solanezumab Alzheimer's Disease Therapeutics and Diagnostics Introduction
        11.4.4 Solanezumab Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022)
        11.4.5 Solanezumab Recent Developments
    11.5 Gantenerumab
        11.5.1 Gantenerumab Company Details
        11.5.2 Gantenerumab Business Overview
        11.5.3 Gantenerumab Alzheimer's Disease Therapeutics and Diagnostics Introduction
        11.5.4 Gantenerumab Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022)
        11.5.5 Gantenerumab Recent Developments
    11.6 Verubecestat
        11.6.1 Verubecestat Company Details
        11.6.2 Verubecestat Business Overview
        11.6.3 Verubecestat Alzheimer's Disease Therapeutics and Diagnostics Introduction
        11.6.4 Verubecestat Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022)
        11.6.5 Verubecestat Recent Developments
    11.7 Pfizer
        11.7.1 Pfizer Company Details
        11.7.2 Pfizer Business Overview
        11.7.3 Pfizer Alzheimer's Disease Therapeutics and Diagnostics Introduction
        11.7.4 Pfizer Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022)
        11.7.5 Pfizer Recent Developments
    11.8 Eisai
        11.8.1 Eisai Company Details
        11.8.2 Eisai Business Overview
        11.8.3 Eisai Alzheimer's Disease Therapeutics and Diagnostics Introduction
        11.8.4 Eisai Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022)
        11.8.5 Eisai Recent Developments
    11.9 Actavis
        11.9.1 Actavis Company Details
        11.9.2 Actavis Business Overview
        11.9.3 Actavis Alzheimer's Disease Therapeutics and Diagnostics Introduction
        11.9.4 Actavis Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022)
        11.9.5 Actavis Recent Developments
    11.10 Lundbeck
        11.10.1 Lundbeck Company Details
        11.10.2 Lundbeck Business Overview
        11.10.3 Lundbeck Alzheimer's Disease Therapeutics and Diagnostics Introduction
        11.10.4 Lundbeck Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022)
        11.10.5 Lundbeck Recent Developments
    11.11 Daiichi Sankyo
        11.11.1 Daiichi Sankyo Company Details
        11.11.2 Daiichi Sankyo Business Overview
        11.11.3 Daiichi Sankyo Alzheimer's Disease Therapeutics and Diagnostics Introduction
        11.11.4 Daiichi Sankyo Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022)
        11.11.5 Daiichi Sankyo Recent Developments
    11.12 Novartis
        11.12.1 Novartis Company Details
        11.12.2 Novartis Business Overview
        11.12.3 Novartis Alzheimer's Disease Therapeutics and Diagnostics Introduction
        11.12.4 Novartis Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022)
        11.12.5 Novartis Recent Developments
    11.13 TauRx
        11.13.1 TauRx Company Details
        11.13.2 TauRx Business Overview
        11.13.3 TauRx Alzheimer's Disease Therapeutics and Diagnostics Introduction
        11.13.4 TauRx Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022)
        11.13.5 TauRx Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Biomarkers
    Table 3. Key Players of Cholinesterase inhibitors
    Table 4. Key Players of NMDA receptor antagonists
    Table 5. Key Players of Brain imaging
    Table 6. Key Players of Blood tests
    Table 7. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 8. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Region (2017-2022)
    Table 11. Global Alzheimer's Disease Therapeutics and Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Region (2023-2028)
    Table 13. Alzheimer's Disease Therapeutics and Diagnostics Market Trends
    Table 14. Alzheimer's Disease Therapeutics and Diagnostics Market Drivers
    Table 15. Alzheimer's Disease Therapeutics and Diagnostics Market Challenges
    Table 16. Alzheimer's Disease Therapeutics and Diagnostics Market Restraints
    Table 17. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Share by Players (2017-2022)
    Table 19. Global Top Alzheimer's Disease Therapeutics and Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Therapeutics and Diagnostics as of 2021)
    Table 20. Ranking of Global Top Alzheimer's Disease Therapeutics and Diagnostics Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Alzheimer's Disease Therapeutics and Diagnostics Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Alzheimer's Disease Therapeutics and Diagnostics Product Solution and Service
    Table 24. Date of Enter into Alzheimer's Disease Therapeutics and Diagnostics Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share by Type (2017-2022)
    Table 28. Global Alzheimer's Disease Therapeutics and Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share by Type (2023-2028)
    Table 30. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Share by Application (2017-2022)
    Table 32. Global Alzheimer's Disease Therapeutics and Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Share by Application (2023-2028)
    Table 34. North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 35. North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 36. North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 37. North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 38. North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 39. North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 41. Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 42. Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 43. Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 44. Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 50. Asia Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 51. Asia Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Size by Region (2023-2028) & (US$ Million)
    Table 52. Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 53. Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 54. Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 55. Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 56. Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 57. Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 64. Namenda Company Details
    Table 65. Namenda Business Overview
    Table 66. Namenda Alzheimer's Disease Therapeutics and Diagnostics Product
    Table 67. Namenda Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 68. Namenda Recent Developments
    Table 69. Aricept Company Details
    Table 70. Aricept Business Overview
    Table 71. Aricept Alzheimer's Disease Therapeutics and Diagnostics Product
    Table 72. Aricept Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 73. Aricept Recent Developments
    Table 74. Exelon Company Details
    Table 75. Exelon Business Overview
    Table 76. Exelon Alzheimer's Disease Therapeutics and Diagnostics Product
    Table 77. Exelon Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 78. Exelon Recent Developments
    Table 79. Solanezumab Company Details
    Table 80. Solanezumab Business Overview
    Table 81. Solanezumab Alzheimer's Disease Therapeutics and Diagnostics Product
    Table 82. Solanezumab Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 83. Solanezumab Recent Developments
    Table 84. Gantenerumab Company Details
    Table 85. Gantenerumab Business Overview
    Table 86. Gantenerumab Alzheimer's Disease Therapeutics and Diagnostics Product
    Table 87. Gantenerumab Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 88. Gantenerumab Recent Developments
    Table 89. Verubecestat Company Details
    Table 90. Verubecestat Business Overview
    Table 91. Verubecestat Alzheimer's Disease Therapeutics and Diagnostics Product
    Table 92. Verubecestat Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 93. Verubecestat Recent Developments
    Table 94. Pfizer Company Details
    Table 95. Pfizer Business Overview
    Table 96. Pfizer Alzheimer's Disease Therapeutics and Diagnostics Product
    Table 97. Pfizer Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 98. Pfizer Recent Developments
    Table 99. Eisai Company Details
    Table 100. Eisai Business Overview
    Table 101. Eisai Alzheimer's Disease Therapeutics and Diagnostics Product
    Table 102. Eisai Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 103. Eisai Recent Developments
    Table 104. Actavis Company Details
    Table 105. Actavis Business Overview
    Table 106. Actavis Alzheimer's Disease Therapeutics and Diagnostics Product
    Table 107. Actavis Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 108. Actavis Recent Developments
    Table 109. Lundbeck Company Details
    Table 110. Lundbeck Business Overview
    Table 111. Lundbeck Alzheimer's Disease Therapeutics and Diagnostics Product
    Table 112. Lundbeck Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 113. Lundbeck Recent Developments
    Table 114. Daiichi Sankyo Company Details
    Table 115. Daiichi Sankyo Business Overview
    Table 116. Daiichi Sankyo Alzheimer's Disease Therapeutics and Diagnostics Product
    Table 117. Daiichi Sankyo Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 118. Daiichi Sankyo Recent Developments
    Table 119. Novartis Company Details
    Table 120. Novartis Business Overview
    Table 121. Novartis Alzheimer's Disease Therapeutics and Diagnostics Product
    Table 122. Novartis Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 123. Novartis Recent Developments
    Table 124. TauRx Company Details
    Table 125. TauRx Business Overview
    Table 126. TauRx Alzheimer's Disease Therapeutics and Diagnostics Product
    Table 127. TauRx Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 128. TauRx Recent Developments
    Table 129. Research Programs/Design for This Report
    Table 130. Key Data Information from Secondary Sources
    Table 131. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Type: 2021 VS 2028
    Figure 2. Biomarkers Features
    Figure 3. Cholinesterase inhibitors Features
    Figure 4. NMDA receptor antagonists Features
    Figure 5. Brain imaging Features
    Figure 6. Blood tests Features
    Figure 7. Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Application: 2021 VS 2028
    Figure 8. Drugs Market Case Studies
    Figure 9. Diagnostics Market Case Studies
    Figure 10. Alzheimer's Disease Therapeutics and Diagnostics Report Years Considered
    Figure 11. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Region: 2021 VS 2028
    Figure 14. Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Players in 2021
    Figure 15. Global Top Alzheimer's Disease Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Therapeutics and Diagnostics as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Alzheimer's Disease Therapeutics and Diagnostics Revenue in 2021
    Figure 17. North America Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Alzheimer's Disease Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 19. North America Alzheimer's Disease Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 20. North America Alzheimer's Disease Therapeutics and Diagnostics Market Size Share by Country (2017-2028)
    Figure 21. United States Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size Share by Country (2017-2028)
    Figure 27. Germany Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Size Share by Region (2017-2028)
    Figure 37. China Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size Share by Country (2017-2028)
    Figure 47. Mexico Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Alzheimer's Disease Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Alzheimer's Disease Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Alzheimer's Disease Therapeutics and Diagnostics Market Size Share by Country (2017-2028)
    Figure 53. Turkey Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Namenda Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022)
    Figure 57. Aricept Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022)
    Figure 58. Exelon Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022)
    Figure 59. Solanezumab Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022)
    Figure 60. Gantenerumab Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022)
    Figure 61. Verubecestat Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022)
    Figure 62. Pfizer Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022)
    Figure 63. Eisai Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022)
    Figure 64. Actavis Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022)
    Figure 65. Lundbeck Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022)
    Figure 66. Daiichi Sankyo Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022)
    Figure 67. Novartis Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022)
    Figure 68. TauRx Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2017-2022)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Namenda
Aricept
Exelon
Solanezumab
Gantenerumab
Verubecestat
Pfizer
Eisai
Actavis
Lundbeck
Daiichi Sankyo
Novartis
TauRx
Frequently Asked Questions
Alzheimer's Disease Therapeutics and Diagnostics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Alzheimer's Disease Therapeutics and Diagnostics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Alzheimer's Disease Therapeutics and Diagnostics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports